5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo

Brain Research

Volumn 1147, Issue 1, 2007, Pages 148-153

  Imbesi, Marta ^a   Zavoreo, Iris ^a   Uz, Tolga ^a   Sharma, Rajiv P ^a   Dimitrijevic, Nikola ^a   Manev, Hari ^a   Manev, Radmila ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 Lipoxygenase (5 LOX, 5 LO); 5 Lipoxygenase activating protein (FLAP); AMPA; Glutamate

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; MALE; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PHOSPHORYLATION; POSTHUMOUS CARE; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELLS, CULTURED; INDOLES; LIPOXYGENASE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; NEURONS; PHOSPHORYLATION; PREFRONTAL CORTEX; RECEPTORS, AMPA;

EID: 34147094108     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.012     Document Type: Article

References (41)

1. Allison D.W., Gelfand V.I., Spector I., and Craig A.M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18 (1998) 2423-2436
2. Alt A., Weiss B., Ogden A.M., Li X., Gleason S.D., Calligaro D.O., Bleakman D., and Witkin J.M. In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainite receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders. Psychopharmacology (Berl) 185 (2006) 240-247
3. Ashby M.C., Maier S.R., Nishimune A., and Henley J.M. Lateral diffusion drives constitutive exchange of AMPA receptors at dendritic spines and is regulated by spine morphology. J. Neurosci. 26 (2006) 7046-7055
4. Barria A., Muller D., Derkach V., Griffith L.C., and Soderling T.R. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276 (1997) 2042-2045
5. Bishnoi M., Patil C.S., Kumar A., and Kulkarni S.K. Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice. Pharmacology 79 (2007) 34-41
6. Boudreau A.C., and Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J. Neurosci. 25 (2005) 9144-9151
7. Chinnici C.M., Yao Y., and Pratico D. The 5-lipoxygenase enzymatic pathway in the mouse brain: Young versus old. Neurobiol. Aging (2006) (Epub ahead of print)
8. Ciceri P., Rabuffetti M., Monopoli A., and Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol. 133 (2001) 1323-1329
9. Du J., Suzuki K., Wei Y., Wang Y., Blumenthal R., Chen Z., Falke C., Zarate Jr. C.A., and Manji H.K. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology (2006) (Epub ahead of print)
10. Firuzi O., Ding T., and Pratico D. Absence of 5-Lipoxygenase Enzyme Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease. Program No. 662.4. Abstract Viewer/Itinerary Planner (2005), Society for Neuroscience, Washington, DC
11. Gao C., Sun X., and Wolf M.E. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J. Neurochem. (2006) (Epub ahead of print)
12. Ge Q.F., Wei E.Q., Zhang W.P., Hu X., Huang X.J., Zhang L., Song Y., Ma Z.Q., Chen Z., and Luo J.H. Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons. J. Neurochem. 97 (2006) 992-1004
13. Genoux D., Haditsch U., Knobloch M., Michalon A., Storm D., and Mansuy I.M. Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418 (2002) 970-975
14. 2+/calmodulin-dependent protein kinase II in cultured prefrontal cortical neurons. Mol. Pharmacol. 69 (2006) 813-822
15. Ho O.H., Delgado J.Y., and O'Dell T.J. Phosphorylation of proteins involved in activity-dependent forms of synaptic plasticity is altered in hippocampal slices maintained in-vitro. J. Neurochem. 91 (2004) 1344-1357
16. Jawien J., Gajda M., Rudling M., Mateuszuk L., Olszanecki R., Guzik T.J., Cichocki T., Chlopicki S., and Korbut R. Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur. J. Clin. Invest. 36 (2006) 141-146
17. Kurtuncu M., Battista N., Uz T., Spagnuolo P., Dimitrijevic N., Pasquariello N., Manev R., Maccarrone M., and Manev H. 5-Lipoxygenase Gene Disruption in Mice Alters their Behavior, Cocaine Responsiveness, and the Brain Endocanabinoid System. Program No. 800.6. Abstract Viewer/Itinerary Planner (2005), Society for Neuroscience, Washington, DC
18. Mammen A.L., Kameyama K., Roche K.W., and Huganir R.L. Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II. J. Biol. Chem. 272 (1997) 32528-32533
19. Mayburd A.L., Martlinez A., Sackett D., Liu H., Shih J., Tauler J., Avis I., and Mulshine J.L. Ingenuity network-assisted transcription profiling: identification of a new pharmacologic mechanism for MK886. Clin. Cancer Res. 12 (2006) 1820-1827
20. Mead A.N., Morris H.V., Dixon C.I., Rulten S.L., Mayne L.V., Zamanillo D., and Stephens D.N. AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice. Behav. Neurosci. 120 (2006) 241-248
21. Menard C., Valastro B., Martel M.A., Chartier E., Marineau A., Baudry M., and Massicotte G. AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A(2) and 5-lipoxygenase activities. Hippocampus 15 (2005) 370-380
22. Palmer C.L., Cotton L., and Henley J.M. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol. Rev. 57 (2005) 253-277
23. Provost P., Samuelsson B., and Radmark O. Interaction of 5-lipoxygenase with cellular proteins. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1881-1885
24. Provost P., Doucet J., Stock A., Gerisch G., Samuelsson B., and Radmark O. Coactosin-like protein, a human F-actin-binding protein: critical role of lysine-75. Biochem. J. 359 Pt. 2 (2001) 255-263
25. Qu T., Uz T., and Manev H. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol. Aging 21 (2000) 647-652
26. Radmark O., and Samuelsson B. Regulation of 5-lipoxygenase enzyme activity. Biochem. Biophys. Res. Commun. 338 (2005) 102-110
27. Rakonjac M., Fischer L., Provost P., Werz O., Steinhilber D., Samuelsson B., and Radmark O. Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13150-13155
28. Roche K.W., Tingley W.G., and Huganir R.L. Glutamate receptor phosphorylation and synaptic plasticity. Curr. Opin. Neurobiol. 4 (1994) 383-388
29. Roche K.W., O'Brien R.J., Mammen A.L., Bernhardt J., and Huganir R.L. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16 (1996) 1179-1188
30. St-Gelais F., Menard C., Congar P., Trudeau L.E., and Massicotte G. Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus 14 (2004) 319-325
31. Sun X., Zhao Y., and Wolf M.E. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J. Neurosci. 25 (2005) 7342-7351
32. Uz T., Pesold C., Longone P., and Manev H. Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J. 12 (1998) 439-449
33. Uz T., Dimitrijevic N., Tueting P., and Manev H. 5-Lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor. Neurol. Neurosci. 20 (2002) 15-20
34. Vickers P.J. 5-Lipoxygenase-activating protein (FLAP). J. Lipid Mediators Cell Signalling 12 (1995) 185-194
35. Walters C.L., Wang B.C., Godfrey M., Sun D., Funk C.D., and Blendy J.A. Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Psychopharmacology (Berl.) 170 (2003) 124-131
36. Wang J.Q., Arora A., Yang L., Parelkar N.K., Zhang G., Liu X., Choe E.S., and Mao L. Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol. Neurobiol. 32 (2005) 237-249
37. Werz O., and Steinhilber D. Development of 5-lipoxygenase inhibitors-Lessons from cellular enzyme regulation. Biochem. Pharmacol. 70 (2005) 327-333
38. Zhang L., Zhang W.P., Hu H., Wang M.L., Sheng W.W., Yao H.T., Ding W., Chen Z., and Wei E.Q. Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology 26 (2006) 99-106
39. Zhang X., Lee T.H., Davidson C., Lazarus C., Wetsel W.C., and Ellinwood E.H. Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. Neuropsychopharmacology 32 (2007) 377-387
40. Zhou Q., Xiao M., and Nicoll R.A. Contribution of cytoskeleton to the internalization of AMPA receptors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1261-1266
41. Zhou Y., Wei E.Q., Fang S.H., Chu L.S., Wang M.L., Zhang W.P., Yu G.L., Ye Y.L., Lin S.C., and Chen Z. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci. (2006) (Epub ahead of print)